Published in Clin Exp Immunol on March 01, 1983
Human milk contains proteins that stimulate and suppress T lymphocyte proliferation. Clin Exp Immunol (1990) 0.95
Serum concentration of pregnancy specific and pregnancy-associated proteins in early gestation. Arch Gynecol (1986) 0.81
Immunohistochemical localization of murine alpha 1-pregnancy-associated protein (alpha 1-PAP) in non-pregnant females: a comparative study with human pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG). Clin Exp Immunol (1985) 0.78
Deficiency of serum "pregnancy-associated" alpha 2-glycoprotein alpha 2-PAG): association with disease. J Clin Pathol (1986) 0.75
Serum levels of pregnancy associated alpha 2-glycoprotein (alpha 2-PAG) during pregnancy in autoimmune thyroid disease: relationship to disease activity. Clin Exp Immunol (1985) 0.75
A simple method for producing antibody specific to a single selected diffusible antigen. Lancet (1966) 5.00
Rapid active transport of immunoglobulin A from blood to bile. J Exp Med (1978) 3.62
Studies on pregnancy-associated globulin. Clin Exp Immunol (1973) 1.50
In vivo and in vitro binding of IgA to the plasma membrane of hepatocytes. Scand J Immunol (1978) 1.47
Biological and clinical significance of pregnancy-associated alpha2-glycorprotein (alpha/-PAG)-a review. Invest Cell Pathol (1981) 1.18
Differentiation of cord blood lymphocytes into IgA-producing cells in response to breast milk stimulatory factor. Clin Immunol Immunopathol (1979) 1.05
Identification of pregnancy-associated alpha-macroglobulin on the surface of peripheral blood leucocyte populations. Clin Exp Immunol (1977) 0.98
Immunosuppressive effect of human pregnancy zone protein on H-2 incompatible mouse heart allografts. Acta Pathol Microbiol Scand C (1978) 0.96
Simultaneous visualization of two antigens in the same tissue section by combining immunoperoxidase with immunofluorescence techniques. J Histochem Cytochem (1979) 0.93
Basic levels of the immuno suppressive serum protein PZ in women-influence of age, parity, gonadotrophins and estrogens. Acta Obstet Gynecol Scand (1977) 0.92
Study of pregnancy-associated alpha2-glycoprotein in relation to populations of human blood leucocytes. Int Arch Allergy Appl Immunol (1979) 0.92
Electron microscopic demonstration of viral particles in sudden infant death syndrome. Ultrastruct Pathol (1981) 0.90
Inhibition of the pokeweed mitogen-induced response of normal peripheral blood lymphocytes by humoral components of colostrum. Clin Exp Immunol (1981) 0.87
Letter: Immunosuppressive effect of pregnancy-associated alpha2-macroglobulin. Lancet (1975) 0.86
Relationship of pregnancy-associated alpha2-glycoprotein (alpha2-PAG) to peripheral blood leucocytes. Scand J Immunol (1978) 0.83
Antigen handling by the gut. Arch Dis Child (1978) 0.83
Localisation of embryonic prealbumin in formalin-fixed human fetal and adult tissue. J Clin Pathol (1981) 0.81
Pregnancy-associated globulin in body fluids of pregnant women. Tohoku J Exp Med (1977) 0.79
Unlabeled antibody peroxidase-antiperoxidase method combined with direct immunofluorescence. J Histochem Cytochem (1981) 0.78
Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet (1991) 7.87
Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry (1982) 7.37
A simple method for producing antibody specific to a single selected diffusible antigen. Lancet (1966) 5.00
Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol (1990) 4.60
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer (1994) 4.37
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29
The genetic attributable risk of breast and ovarian cancer. Cancer (1996) 3.55
Screening for depression in a community sample. Understanding the discrepancies between depression symptom and diagnostic scales. Arch Gen Psychiatry (1982) 3.47
Statistical criteria in the interpretation of epidemiologic data. Am J Public Health (1987) 3.40
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res (1989) 3.35
Lung cancer and exposure to tobacco smoke in the household. N Engl J Med (1990) 3.23
Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol (1986) 2.93
The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81
FK 506: an immunosuppressant for the 1990s? Lancet (1991) 2.80
Excitation of pyramidal tract cells by intracortical microstimulation: effective extent of stimulating current. J Neurophysiol (1968) 2.80
Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis (1978) 2.59
Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol (1999) 2.48
Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48
Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am J Hum Genet (1989) 2.37
FK-506--how much potential? Immunol Today (1989) 2.20
Familial ovarian cancer: a population-based case-control study. Am J Epidemiol (1988) 2.15
Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines. Immunology (1983) 1.99
Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol (2001) 1.95
Predicting measures of motor performance from multiple cortical spike trains. Science (1970) 1.88
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med (1995) 1.88
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation (1996) 1.86
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81
Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol (1991) 1.76
Prognostic significance of inappropriate production of pregnancy proteins by breast cancers. Lancet (1976) 1.73
Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol (1992) 1.71
A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group. Cancer Epidemiol Biomarkers Prev (1996) 1.70
Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene (1995) 1.69
Factors associated with risk of stress urinary incontinence in women. Nurs Res (1994) 1.66
Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With oarticular reference to the liver. Transplantation (1996) 1.65
Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation (1995) 1.63
Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Br J Cancer (1992) 1.62
Fenbendazole treatment without environmental decontamination eradicates Syphacia muris from all rats in a large, complex research institution. Contemp Top Lab Anim Sci (2000) 1.61
Depression and its treatment in a US urban community-1975-1976. Arch Gen Psychiatry (1981) 1.61
Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol (2000) 1.60
Plasmin, fibrin degradation and angiogenesis. Nat Med (1996) 1.59
Multiple births and maternal risk of breast cancer. Am J Epidemiol (1989) 1.57
The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56
Tubal sterilization and the risk of endometrial cancer. Int J Cancer (1996) 1.54
Polycystic ovaries and the risk of breast cancer. Am J Epidemiol (1991) 1.54
Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol (1996) 1.53
Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study. Cancer (1990) 1.52
Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation (1995) 1.51
Studies on pregnancy-associated globulin. Clin Exp Immunol (1973) 1.50
Maternal pattern of reproduction and risk of breast cancer in daughters: results from the Utah Population Database. J Natl Cancer Inst (1994) 1.50
The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat (1993) 1.50
On the comparison of effects. Am J Public Health (1987) 1.49
Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol (1995) 1.49
Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood (2001) 1.47
The pathological and biological nature of screen-detected breast carcinomas: a morphological and immunohistochemical study. J Pathol (1997) 1.47
Age at and time since: modeling temporal aspects of exposure. Epidemiology (1997) 1.47
Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J Immunol (2000) 1.47
Pregnancy specific beta1-glycoprotein--a product of the syncytiotrophoblast. Experientia (1976) 1.46
Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol (1992) 1.42
Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity. Lancet (1970) 1.42
Evidence for an immune complex vasculitis in neonatal necrotising enterocolitis. J Clin Pathol (1981) 1.39
Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer (1991) 1.39
Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal. Transplantation (1981) 1.38
Toxicity of the immune suppressant cyclosporin A in the rat. J Pathol (1982) 1.38
Relationship between breast histopathology and family history of breast cancer. Cancer (1993) 1.38
p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. J Pathol (1991) 1.35
Concentrations of serum alpha-2-macroglobulin in twins. Nature (1969) 1.33
Immunobiology of cyclosporin A--a review. Aust J Exp Biol Med Sci (1983) 1.31
Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit (1995) 1.30
C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value. J Urol (1996) 1.30
Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc (1994) 1.29
Differential misclassification and the assessment of gene-environment interactions in case-control studies. Am J Epidemiol (1998) 1.27
Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs. Immunology (1983) 1.27
Psychiatric disorders in the relatives of probands with affective disorders. The Yale University--National Institute of Mental Health Collaborative Study. Arch Gen Psychiatry (1984) 1.26
Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol (1994) 1.25
An evaluation of the family history method for ascertaining psychiatric disorders. Arch Gen Psychiatry (1982) 1.24
Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant (2006) 1.24
Risk of contralateral breast cancer: associations with factors related to initial breast cancer. Am J Epidemiol (1988) 1.24
Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth. J Pathol (1987) 1.23
Fundamental Ca2+ signaling mechanisms in mouse dendritic cells: CRAC is the major Ca2+ entry pathway. J Immunol (2001) 1.23
Evaluation of the direct injection of antigen into a peripheral lymph node for the production of humoral and cell-mediated immunity in the guinea-pig. Immunology (1968) 1.23
c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study. Histopathology (1990) 1.22
Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. Transplantation (1998) 1.22
Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. Am J Transplant (2013) 1.22
Cyclosporin: use outside transplantation. BMJ (1991) 1.22
Designer dendritic cells for tolerance induction: guided not misguided missiles. Trends Immunol (2001) 1.21
Evaluation of carrageenan as an immunosuppressive agent and mediator of intravascular coagulation. Biomedicine (1976) 1.20
Dendritic cells and immune regulation in the liver. Gut (2003) 1.19
Biological and clinical significance of pregnancy-associated alpha2-glycorprotein (alpha/-PAG)-a review. Invest Cell Pathol (1981) 1.18
Effect of combined oestrogen-progestogen oral contraceptives on serum-levels of alpha 2-macroglobulin, transferrin, albumin, and IgG. Lancet (1970) 1.18
Delivery of rapamycin to dendritic cells using degradable microparticles. J Control Release (2008) 1.17
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation (1997) 1.17
Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses. Immunology (1995) 1.17
Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation (1994) 1.16
Excising basal cell carcinomas: comparing the performance of general practitioners, hospital skin specialists and other hospital specialists. Clin Exp Dermatol (2008) 1.16
Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol (1997) 1.16
Autoantibodies in children with coeliac disease. Clin Exp Immunol (1973) 1.15
New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells. Am J Transplant (2008) 1.14